Correction to: Andexanet Alfa: First Global Approval

被引：0

|

作者：

Young-A Heo

机构：

[1] Springer,

来源：

Drugs | 2018年 / 78卷 / 12期

关键词：

D O I：

10.1007/s40265-018-0954-y

中图分类号：

学科分类号：

摘要：

The article Andexanet Alfa: First Global Approval, written by Young-A Heo, was originally published Online First without open access.

引用

收藏

页码：1285 / 1285

相关论文

共 50 条

[1] Andexanet Alfa: First Global Approval
Heo, Young-A
[J]. DRUGS, 2018, 78 (10) : 1049 - 1055
[2] Andexanet Alfa: First Global Approval
Young-A Heo
[J]. Drugs, 2018, 78 : 1049 - 1055
[3] Andexanet Alfa: First Global Approval (vol 78, pg 1049, 2018)
Heo, Young-A
[J]. DRUGS, 2018, 78 (12) : 1285 - 1285
[4] Correction to: Efanesoctocog Alfa: First Approval
Susan J. Keam
[J]. Drugs, 2023, 83 (10) : 953 - 953
[5] Cerliponase Alfa: First Global Approval
Markham, Anthony
[J]. DRUGS, 2017, 77 (11) : 1247 - 1249
[6] Elosulfase alfa: First Global Approval
Sanford, Mark
Lo, Jin Han
[J]. DRUGS, 2014, 74 (06) : 713 - 718
[7] Elosulfase alfa: First Global Approval
Mark Sanford
Jin Han Lo
[J]. Drugs, 2014, 74 : 713 - 718
[8] Sebelipase Alfa: First Global Approval
Shirley, Matt
[J]. DRUGS, 2015, 75 (16) : 1935 - 1940
[9] Sebelipase Alfa: First Global Approval
Matt Shirley
[J]. Drugs, 2015, 75 : 1935 - 1940
[10] Cerliponase Alfa: First Global Approval
Anthony Markham
[J]. Drugs, 2017, 77 : 1247 - 1249

← 1 2 3 4 5 →